Clinical trials
Recruiting Lymphoma, Follicular trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Regeneron Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Celgene | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Nurix Therapeutics, Inc. | 1 |
| Pfizer | 1 |
| Schrödinger, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 14 |
| Lymphoma, B-Cell, Marginal Zone | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Mantle-Cell | 5 |
| Waldenstrom Macroglobulinemia | 5 |
| Lymphoma, Non-Hodgkin | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Recurrence | 3 |
| Lymphoma, B-Cell | 2 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.